Hypnotherapy may offer real benefits for cancer patient care

byEdith Cowan UniversityCredit: PexelsHypnotherapy could offer a host of benefits to cancer patients; however, arecent studypublished inComplementary Therapies in Clinical Prac

Updated on: July 05,2024

Hypnotherapy may offer real benefits for cancer patient care

byEdith Cowan UniversityCredit: PexelsHypnotherapy could offer a host of benefits to cancer patients; however, arecent studypublished inComplementary Therapies in Clinical Prac

Updated on:July 05,2024

Chronic diseases monitored in primary care could lead to unnecessary testing

by University of BristolCredit: CC0 Public DomainGuidelines used by GPs to monitor chronic diseases are based on expert opinion rather than evidence, according to a review of the guidelines by Na

Updated on: May 05,2024

Chronic diseases monitored in primary care could lead to unnecessary testing

by University of BristolCredit: CC0 Public DomainGuidelines used by GPs to monitor chronic diseases are based on expert opinion rather than evidence, according to a review of the guidelines by Na

Updated on:May 05,2024

COVID-19 booster vaccine doses strengthen immunity in blood cancer patients, shows study

by University of SouthamptonCredit: Pixabay/CC0 Public DomainResearch by the University of Southampton into the effectiveness of COVID-19 vaccines in people with lymphoma has shown that repeated

Updated on: February 20,2024

COVID-19 booster vaccine doses strengthen immunity in blood cancer patients, shows study

by University of SouthamptonCredit: Pixabay/CC0 Public DomainResearch by the University of Southampton into the effectiveness of COVID-19 vaccines in people with lymphoma has shown that repeated

Updated on:February 20,2024

Researchers use AI to establish molecular tumor classification and prognosis in patients with colorectal cancer

by University of ZurichThe image-based consensus molecular subtypes (imCMS) model can be used to predict the molecular classification of each individual image region in patient tumor samples. Thi

Updated on: June 08,2024

Researchers use AI to establish molecular tumor classification and prognosis in patients with colorectal cancer

by University of ZurichThe image-based consensus molecular subtypes (imCMS) model can be used to predict the molecular classification of each individual image region in patient tumor samples. Thi

Updated on:June 08,2024

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Updated on: August 28,2024

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Updated on:August 28,2024

Identifying key markers in pancreatic cancer progression using a new analysis pipeline

byJohns Hopkins UniversityNovel computational pipeline developed by Johns Hopkins Kimmel Cancer Researchers to identify early molecular and cellular progression to pancreatic ductal adenocarcino

Updated on: September 10,2024

Identifying key markers in pancreatic cancer progression using a new analysis pipeline

byJohns Hopkins UniversityNovel computational pipeline developed by Johns Hopkins Kimmel Cancer Researchers to identify early molecular and cellular progression to pancreatic ductal adenocarcino

Updated on:September 10,2024

Tissue stiffness is a "mosh pit" where cancer cells thrive

by Leslie Orr,University of Rochester Medical CenterCredit: CC0 Public DomainImagine being at a packed concert hall with a mosh pit full of dancers creating a wall against outsiders. When target

Updated on: March 24,2024

Tissue stiffness is a "mosh pit" where cancer cells thrive

by Leslie Orr,University of Rochester Medical CenterCredit: CC0 Public DomainImagine being at a packed concert hall with a mosh pit full of dancers creating a wall against outsiders. When target

Updated on:March 24,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on: January 16,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on:January 16,2024

Fighting cancer on Earth and in space using high-energy protons

byUS Department of EnergyLeft: production rate as a function of proton energy of parent radioisotopes selenium-72 (Se-72) (1) & germanium-68 (Ge-68) (2). Right, a Positron Emission Tomograph

Updated on: December 28,2023

Fighting cancer on Earth and in space using high-energy protons

byUS Department of EnergyLeft: production rate as a function of proton energy of parent radioisotopes selenium-72 (Se-72) (1) & germanium-68 (Ge-68) (2). Right, a Positron Emission Tomograph

Updated on:December 28,2023

AI better than human eye at predicting brain metastasis outcomes, find researchers

by York UniversityArchitecture of (a) vanilla 3D residual network (baseline), (b) the 3D residual network with CBAM attention, (c) the proposed self-attention-guided 3D residual network, (d) the

Updated on: February 20,2024

AI better than human eye at predicting brain metastasis outcomes, find researchers

by York UniversityArchitecture of (a) vanilla 3D residual network (baseline), (b) the 3D residual network with CBAM attention, (c) the proposed self-attention-guided 3D residual network, (d) the

Updated on:February 20,2024

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Updated on: February 23,2024

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Updated on:February 23,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on: March 30,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on:March 30,2024